Management of Type 1 Diabetes in Pregnancy - Test2 - elhamkhani - TriplyDB

Management of Type 1 Diabetes in Pregnancy

Management of Type 1 Diabetes in Pregnancy

http://www.wikidata.org/entity/Q26747535

about

Polyglandular Autoimmune Syndrome in pregnancy: case report.Dynamics of diabetes and obesity: Epidemiological perspective.The emerging role of metformin in gestational diabetes mellitus.Maternal and fetal outcomes of pregnant women with type 1 diabetes, a national population study.The Impact of Kidney Development on the Life Course: A Consensus Document for Action.Premarriage Counseling in Type 1 Diabetes.

P2860

Q37462834-D8A97793-68FD-4E54-A060-FE11747B7EA9 Q38994655-D6F2B1AF-1481-40C2-A42D-D3413F81E172 Q38996030-67432F7F-4090-4F8F-B109-9CBFA8BD2BAD Q47140145-1A69E58C-ADCE-4BE3-89E1-A751718DF734 Q54016287-4087C665-073F-4E21-A6BF-720192536B86 Q55452741-026A1E48-4DBF-4CDF-AE27-DDC9AA45A206

P2860

Management of Type 1 Diabetes in Pregnancy

http://www.wikidata.org/entity/Q26747535

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Management of Type 1 Diabetes in Pregnancy

@ast

Management of Type 1 Diabetes in Pregnancy

@en

Management of Type 1 Diabetes in Pregnancy

@nl

type

label

Management of Type 1 Diabetes in Pregnancy

@ast

Management of Type 1 Diabetes in Pregnancy

@en

Management of Type 1 Diabetes in Pregnancy

@nl

prefLabel

Management of Type 1 Diabetes in Pregnancy

@ast

Management of Type 1 Diabetes in Pregnancy

@en

Management of Type 1 Diabetes in Pregnancy

@nl

P1433

Q26747535-F26B0A2F-4D1D-46A5-B377-5B77D5036D6F

P1476

Q26747535-CED25002-7FE5-4D15-90B3-591ACF952DA1

P2093

Q26747535-67DCD145-761E-4E89-9932-0E33D0B2284B

Q26747535-84256940-F57A-4356-B2F7-3A59CD7BFB6E

P275

Q26747535-4D5E95B9-C14F-4357-8E67-4B2154F8CF4B

P2860

Q26747535-014791ED-6EA4-4664-9F46-547EF0D0B9B1

Q26747535-05664D7E-4CA9-4B6E-B5D1-30E038CB4DC8

Q26747535-05EDE800-905F-4374-BC32-B13E2E5BC5C4

Q26747535-09761050-CD10-4CC0-8DFB-9FC59B9C8A7E

Q26747535-0DC1CCFF-B3C0-4442-BF65-F5FAED91D2AB

Q26747535-0DE81CF7-9AF4-4859-ADC1-8D5C26047BF0

Q26747535-11422E9B-499F-4FAB-BCCA-9EB58EE95C20

Q26747535-1315D0D2-EF89-4E4E-803A-EA2DAF911A89

Q26747535-1494BDE3-FC00-4065-B520-3D10F5D5C2B7

Q26747535-15FE97F0-CCE6-409C-93B3-DFD3EFEC279A

P2888

Q26747535-27490AFB-8E2B-4162-B9E9-D269AC95302A

P304

Q26747535-2D875E7A-3DFB-451E-9611-7DF7CF9549DC

P31

Q26747535-206264A0-792E-4048-B6FB-8A41D7C45088

Q26747535-DEB73CEE-5179-4BC8-B25C-252BAD3D181D

P3181

Q26747535-1DCF417B-10F8-48B3-997A-D3F4EC46F152

P356

Q26747535-86E06BAD-4A3F-4125-B507-18CB23B94D73

P407

Q26747535-0AE023DC-5F2A-4FDC-A303-49DE1E990BE8

P433

Q26747535-44BFA183-7442-429A-A1AF-BDA82CCB8709

P478

Q26747535-296298E5-6540-4FE7-8683-2B74E894D491

P5008

Q26747535-511FEC5F-0D69-4B6B-92BF-579F3F8A2782

P577

Q26747535-2ADA4109-3F05-4765-83BA-F5722DD550E6

Q26747535-5E874B57-932B-4E74-ABD4-B3CCE6BBDEA6

P6179

Q26747535-8FA6249E-39E4-491B-A9B0-1D98D3806BDC

P698

Q26747535-892F1468-3F17-4F35-BC44-D0F9DA93EA73

P921

Q26747535-12A5A0CF-492E-4437-A22B-7C32B8A89862

Q26747535-5B3AA126-2B56-4B39-B81A-B9F51923C9AA

Q26747535-8D83C121-3BF7-49A3-9204-3A3A0DA121C2

P932

Q26747535-93276ABA-8679-4DEE-9AC1-D84DE42AE918

P3181

P356

S11892-016-0765-Z

P1433

Current diabetes report

P1476

Management of Type 1 Diabetes in Pregnancy

@en

P2093

Anna Z Feldman

http://www.w3.org/2001/XMLSchema#string

Florence M Brown

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American Co

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum

The metabolic and mitogenic properties of basal insulin analogues

Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth

Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.

P2888

s11892-016-0765-z

P304

76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2871

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11892-016-0765-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023005128

http://www.w3.org/2001/XMLSchema#string

P698

27337958

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

gestational diabetes

maternal health

P932

4919374

http://www.w3.org/2001/XMLSchema#string